Ask AI

Plotting a Treatment Course for EGFR-Mutated NSCLC: Nursing Considerations and Skill-Based Training for Oncology Nurses and NPs

Enhance your understanding of therapies for EGFR-mutated non-small-cell lung cancer (NSCLC) through a downloadable resource, expert-written ClinicalThought commentary, accredited on-demand webcast, and accompanying downloadable slides.

Share

Program Content

Events

Activities

Nursing Considerations for EGFR Mutated NSCLC
Nursing Considerations When Plotting a Treatment Course for EGFR-Mutated NSCLC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: August 25, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from AstraZeneca and Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

AstraZeneca

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC